MIT Technology Review @techreview
The rate of serious clotting events from the J&J vaccine could be about 1 in 1 million, making them “extremely rare,” according to the FDA. The problem is that the blood clots have struck younger women, whose personal risk from covid-19 is lower. https://t.co/agIqlpEPfr — PolitiTweet.org